Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: Opportunities for antimicrobial stewardship

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 6, 2016, Pages 3743-3750

  Karino, Shigehiko ^a,b   Kaye, Keith S ^a,b   Navalkele, Bhagyashri ^a,b   Nishan, Bakht ^b   Salim, Madiha ^b   Solanki, Shantanu ^b   Pervaiz, Amina ^b   Tashtoush, Nader ^b   Shaikh, Hamadullah ^b   Koppula, Sunitha ^b   Martin, Emily T ^c   Mynatt, Ryan P ^d   Murray, Kyle P ^e   Rybak, Michael J ^b,d,f   Pogue, Jason M ^b,g  

^a DETROIT MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d DETROIT RECEIVING HOSPITAL   (United States)

^e Huron Valley Sinai Hospital   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g SINAI GRACE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; COLISTIN; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPERTENSIVE FACTOR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

ABDOMINAL INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BONE INFECTION; CATHETER INFECTION; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; DIABETES MELLITUS; ENDOCARDITIS; ENTEROBACTERIACEAE; FEMALE; GLOMERULUS FILTRATION RATE; GRAM POSITIVE INFECTION; HEART INFARCTION; HUMAN; HYPERTENSION; INFECTIOUS ARTHRITIS; INTENSIVE CARE; LENGTH OF STAY; LEUKEMIA; LIVER DISEASE; LOADING DRUG DOSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; MICHIGAN; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ACUTE KIDNEY INJURY; ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84973572539     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03011-15     Document Type: Article

References (11)

1. Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Prevalence of antimicrobial use in U.S. acute care hospitals, May-September 2011. JAMA 312:1438-1446. http://dx.doi.org/10.1001/jama.2014.12923.
2. Burgess LD, Drew RH. 2014. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy 34:670-676. http://dx.doi.org/10.1002/phar.1442.
3. Gomes DM, Smotherman C, Birch A, Dupree L, Della Vecchia BJ, Kraemer DF, Jankowski CA. 2014 Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy 34:662-669.
4. Moenster RP, Linneman TW, Finnegan PM, Hand S, Thomas Z, McDonald JR. 2014. Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime. Clin Microbiol Infect 20:O384-O389. http://dx.doi.org/10.1111/1469-0691.12410.
5. Meaney CJ, Hynicka LM, Tsoukleris MG. 2014. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy 34:653-661.
6. Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Jr, Craig W, Billeter M, Dalovisio JR, Levine DP. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82-98. http://dx.doi.org/10.2146/ajhp080434.
7. Lodise TP, Jr, Lomaestro B, Drusano GL. 2007. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 44:357-363. http://dx.doi.org/10.1086/510590.
8. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup. 2004. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204-R212.
9. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network. 2007. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383.
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. 2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580-637.